Lyra Therapeutics (LYRA) Asset Utilization Ratio (2021 - 2025)

Lyra Therapeutics has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.01 in Q4 2025.

• On a quarterly basis, Asset Utilization Ratio fell 52.83% year-over-year to 0.01 in Q4 2025; TTM through Dec 2025 was 0.01, a 52.83% decrease from a year earlier, with the FY2025 full-year figure at 0.01, down 47.09% from the prior year.
• Asset Utilization Ratio was 0.01 for Q4 2025 at Lyra Therapeutics, down from 0.01 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.02 in Q4 2024, with the low at 0.0 in Q4 2021.
• Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.01 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio surged 155.62% in 2022, then slumped 52.83% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.0 in 2021, then soared by 155.62% to 0.01 in 2022, then slipped by 0.35% to 0.01 in 2023, then soared by 78.58% to 0.02 in 2024, then sank by 52.83% to 0.01 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025), per Business Quant data.